BLB&B Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.3M | Buy |
80,824
+557
| +0.7% | +$120K | 0.74% | 32 |
|
|
2026
Q1 | $17.5M | Sell |
80,267
-4,383
| -5% | -$972K | 0.72% | 30 |
|
|
2025
Q4 | $19.3M | Sell |
84,650
-2,906
| -3% | -$662K | 0.81% | 28 |
|
|
2025
Q3 | $20.3M | Buy |
87,556
+269
| +0.3% | +$54.8K | 0.88% | 27 |
|
|
2025
Q2 | $16.2M | Sell |
87,287
-971
| -1% | -$180K | 0.76% | 31 |
|
|
2025
Q1 | $18.5M | Sell |
88,258
-966
| -1% | -$188K | 0.94% | 28 |
|
|
2024
Q4 | $15.9M | Sell |
89,224
-629
| -0.7% | -$116K | 0.81% | 29 |
|
|
2024
Q3 | $17.7M | Buy |
89,853
+2,365
| +3% | +$441K | 0.91% | 28 |
|
|
2024
Q2 | $15M | Buy |
87,488
+9,519
| +12% | +$1.58M | 0.82% | 27 |
|
|
2024
Q1 | $14.2M | Buy |
77,969
+64
| +0.1% | +$11K | 0.8% | 28 |
|
|
2023
Q4 | $12.1M | Sell |
77,905
-392
| -0.5% | -$57.1K | 0.76% | 31 |
|
|
2023
Q3 | $11.7M | Buy |
78,297
+3,096
| +4% | +$455K | 0.83% | 31 |
|
|
2023
Q2 | $10.1M | Buy |
75,201
+5,039
| +7% | +$739K | 0.71% | 36 |
|
|
2023
Q1 | $11.2M | Buy |
70,162
+5,104
| +8% | +$780K | 0.83% | 31 |
|
|
2022
Q4 | $10.5M | Buy |
65,058
+34,480
| +113% | +$5.29M | 0.81% | 31 |
|
|
2022
Q3 | $4.1M | Sell |
30,578
-108
| -0.4% | -$15.5K | 0.34% | 66 |
|
|
2022
Q2 | $4.7M | Sell |
30,686
-547
| -2% | -$83.6K | 0.37% | 65 |
|
|
2022
Q1 | $5.06M | Sell |
31,233
-2,429
| -7% | -$353K | 0.34% | 66 |
|
|
2021
Q4 | $4.56M | Sell |
33,662
-5,392
| -14% | -$637K | 0.3% | 72 |
|
|
2021
Q3 | $4.21M | Buy |
39,054
+3,261
| +9% | +$373K | 0.28% | 75 |
|
|
2021
Q2 | $4.03M | Sell |
35,793
-875
| -2% | -$98.5K | 0.29% | 75 |
|
|
2021
Q1 | $3.97M | Sell |
36,668
-7,650
| -17% | -$818K | 0.31% | 75 |
|
|
2020
Q4 | $4.75M | Buy |
44,318
+3,805
| +9% | +$366K | 0.38% | 67 |
|
|
2020
Q3 | $3.55M | Sell |
40,513
-169
| -0.4% | -$15.9K | 0.36% | 71 |
|
|
2020
Q2 | $3.99M | Sell |
40,682
-1,727
| -4% | -$152K | 0.43% | 67 |
|
|
2020
Q1 | $3.23M | Sell |
42,409
-3,527
| -8% | -$300K | 0.42% | 68 |
|
|
2019
Q4 | $4.07M | Sell |
45,936
-2,818
| -6% | -$234K | 0.42% | 66 |
|
|
2019
Q3 | $3.69M | Sell |
48,754
-2,560
| -5% | -$176K | 0.42% | 67 |
|
|
2019
Q2 | $3.73M | Sell |
51,314
-2,357
| -4% | -$185K | 0.43% | 65 |
|
|
2019
Q1 | $4.33M | Sell |
53,671
-4,316
| -7% | -$353K | 0.51% | 52 |
|
|
2018
Q4 | $5.35M | Sell |
57,987
-1,571
| -3% | -$138K | 0.73% | 36 |
|
|
2018
Q3 | $5.63M | Sell |
59,558
-1,988
| -3% | -$189K | 0.7% | 39 |
|
|
2018
Q2 | $5.7M | Sell |
61,546
-46
| -0.1% | -$4.49K | 0.77% | 35 |
|
|
2018
Q1 | $5.83M | Sell |
61,592
-3,476
| -5% | -$382K | 0.78% | 36 |
|
|
2017
Q4 | $6.29M | Sell |
65,068
-424
| -0.6% | -$40K | 0.9% | 31 |
|
|
2017
Q3 | $5.82M | Sell |
65,492
-5
| -0% | -$381 | 0.9% | 32 |
|
|
2017
Q2 | $4.75M | Buy |
65,497
+407
| +0.6% | +$27.4K | 0.79% | 38 |
|
|
2017
Q1 | $4.24M | Sell |
65,090
-1,445
| -2% | -$90.8K | 0.72% | 41 |
|
|
2016
Q4 | $4.17M | Sell |
66,535
-1,124
| -2% | -$68.6K | 0.73% | 39 |
|
|
2016
Q3 | $4.27M | Sell |
67,659
-277
| -0.4% | -$17.9K | 0.78% | 32 |
|
|
2016
Q2 | $4.21M | Sell |
67,936
-145
| -0.2% | -$8.84K | 0.79% | 38 |
|
|
2016
Q1 | $3.89M | Sell |
68,081
-880
| -1% | -$49K | 0.78% | 36 |
|
|
2015
Q4 | $4.08M | Sell |
68,961
-640
| -0.9% | -$36.9K | 0.86% | 34 |
|
|
2015
Q3 | $3.79M | Buy |
69,601
+2,990
| +4% | +$195K | 0.84% | 35 |
|
|
2015
Q2 | $4.48M | Buy |
66,611
+200
| +0.3% | +$13.1K | 0.93% | 30 |
|
|
2015
Q1 | $3.89M | Buy |
66,411
+1,830
| +3% | +$111K | 0.81% | 41 |
|
|
2014
Q4 | $4.23M | Buy |
64,581
+380
| +0.6% | +$24K | 0.89% | 31 |
|
|
2014
Q3 | $3.71M | Sell |
64,201
-295
| -0.5% | -$16.4K | 0.8% | 40 |
|
|
2014
Q2 | $3.64M | Buy |
64,496
+1,134
| +2% | +$59.5K | 0.78% | 40 |
|
|
2014
Q1 | $3.26M | Buy |
63,362
+5,068
| +9% | +$256K | 0.72% | 44 |
|
|
2013
Q4 | $3.08M | Buy |
58,294
+1,371
| +2% | +$67.4K | 0.74% | 45 |
|
|
2013
Q3 | $2.55M | Sell |
56,923
-280
| -0.5% | -$12.4K | 0.67% | 48 |
|
|
2013
Q2 | $2.37M | Buy |
+57,203
| New | +$2.5M | 0.66% | 48 |
|
Other funds holding ABBV
BLB&B Advisors's ABBV Position: Q2 2026 in Review
BLB&B Advisors increased its AbbVie (ABBV) stake by 0.69% in Q2 2026, buying an estimated $120K and bringing the position to 80,824 shares worth $20.3M. The position accounts for 0.74% of the portfolio, ranked #32.
BLB&B Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- BLB&B Advisors held 80,824 shares of AbbVie worth $20.3M as of Q2 2026.
- BLB&B Advisors bought 557 AbbVie shares in Q2 2026, an estimated $120K.
- AbbVie made up 0.74% of BLB&B Advisors's portfolio in Q2 2026, its #32 holding.
- BLB&B Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on BLB&B Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.